International Stem Cell (ISCO) Operating Expenses (2010 - 2026)
International Stem Cell's Operating Expenses came in at $2.71 million for Q2 2026, up 18.9% from $2.28 million a year earlier.
Powered by 
Analysis
International Stem Cell (ISCO) Operating Expenses (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, International Stem Cell reported Operating Expenses of $9.73 million, up 4.8% year-over-year; for FY2025, it came in at $9.37 million, up 2.3% from FY2024.
- Operating Expenses has increased in each of the last three years, though with a five-year compound annual growth rate of -1.2% (FY2020 to FY2025).
- Going back by year, Operating Expenses was $9.15 million in FY2024 (+8.3%), $8.45 million in FY2023 (+1.1%), $8.36 million in FY2022 (-8.1%) and $9.1 million in FY2021 (-8.5%).
- The Q2 2026 figure represents the highest quarterly Operating Expenses since Q1 2020.
- The fastest year-over-year change in Operating Expenses over five years came in Q2 2026 (growth of 18.9%), and the weakest in Q3 2022 (a decline of 18.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -9.70 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 6.54 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 18.20 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 6.68 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.09 Bn |
| 10 | International Stem Cell | 2.80 Mn | -1.17 Mn | 1.46 Mn | 2.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.71 Mn |
| Dec 31, 2025 | 2.47 Mn |
| Sep 30, 2025 | 2.28 Mn |
| Jun 30, 2025 | 2.28 Mn |
| Mar 31, 2025 | 2.34 Mn |
| Dec 31, 2024 | 2.40 Mn |
| Sep 30, 2024 | 2.27 Mn |
| Jun 30, 2024 | 2.18 Mn |
| Mar 31, 2024 | 2.31 Mn |
| Dec 31, 2023 | 2.31 Mn |
| Sep 30, 2023 | 2.07 Mn |
| Jun 30, 2023 | 1.99 Mn |
| Mar 31, 2023 | 2.08 Mn |
| Dec 31, 2022 | 2.37 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Mar 31, 2022 | 2.00 Mn |
| Dec 31, 2021 | 2.17 Mn |
| Sep 30, 2021 | 2.47 Mn |
| Jun 30, 2021 | 2.24 Mn |
API Access
International Stem Cell Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();